Report cover image

Generics Global Industry Almanac 2019-2028

Publisher MarketLine
Published Dec 20, 2024
Length 558 Pages
SKU # MTLN19599832

Description

Generics Global Industry Almanac 2019-2028Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume , and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
  • All market data and forecasts are adjusted for inflation and all currency conversions used in the creation of this report have been calculated using yearly annual average exchange rates.
  • The global generics market recorded revenues of $394.6 billion in 2023, representing a compound annual growth rate (CAGR) of 7.8% between 2018 and 2023.
  • Market consumption volume increased with a CAGR of 1.4% between 2018 and 2023, to reach a total of 51.4% of total pharma volume in 2023.
  • According to GlobalData, in 2023, Asia-Pacific accounting for a share of 47.7%, was the largest generics market globally. The dominance of the region is driven by its large-scale manufacturing capabilities, cost-competitive production, and robust supply chain infrastructure.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
Reasons to Buy
  • What was the size of the global generics market by value in 2023?
  • What will be the size of the global generics market in 2028?
  • What factors are affecting the strength of competition in the global generics market?
  • How has the market performed over the last five years?
  • How large is the global generics market in relation to its regional counterparts?

Table of Contents

558 Pages
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Competitive landscape
2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions
3 Global Generics
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
4 Macroeconomic Indicators
4.1. Country data
5 Generics in Asia-Pacific
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
6 Generics in Europe
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
7 Macroeconomic Indicators
7.1. Country data
8 Generics in France
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
9 Macroeconomic Indicators
9.1. Country data
10 Generics in Germany
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
11 Macroeconomic Indicators
11.1. Country data
12 Generics in Australia
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis
13 Macroeconomic Indicators
13.1. Country data
14 Generics in Brazil
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis
15 Macroeconomic Indicators
15.1. Country data
16 Generics in Canada
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis
17 Macroeconomic Indicators
17.1. Country data
18 Generics in China
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis
19 Macroeconomic Indicators
19.1. Country data
20 Generics in India
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis
21 Macroeconomic Indicators
21.1. Country data
22 Generics in Indonesia
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis
23 Macroeconomic Indicators
23.1. Country data
24 Generics in Italy
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis
25 Macroeconomic Indicators
25.1. Country data
26 Generics in Japan
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis
27 Macroeconomic Indicators
27.1. Country data
28 Generics in Mexico
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis
29 Macroeconomic Indicators
29.1. Country data
30 Generics in The Netherlands
30.1. Market Overview
30.2. Market Data
30.3. Market Segmentation
30.4. Market outlook
30.5. Five forces analysis
31 Macroeconomic Indicators
31.1. Country data
32 Generics in North America
32.1. Market Overview
32.2. Market Data
32.3. Market Segmentation
32.4. Market outlook
32.5. Five forces analysis
33 Generics in Russia
33.1. Market Overview
33.2. Market Data
33.3. Market Segmentation
33.4. Market outlook
33.5. Five forces analysis
34 Macroeconomic Indicators
34.1. Country data
35 Generics in Scandinavia
35.1. Market Overview
35.2. Market Data
35.3. Market Segmentation
35.4. Market outlook
35.5. Five forces analysis
36 Generics in Singapore
36.1. Market Overview
36.2. Market Data
36.3. Market Segmentation
36.4. Market outlook
36.5. Five forces analysis
37 Macroeconomic Indicators
37.1. Country data
38 Generics in South Africa
38.1. Market Overview
38.2. Market Data
38.3. Market Segmentation
38.4. Market outlook
38.5. Five forces analysis
39 Macroeconomic Indicators
39.1. Country data
40 Generics in South Korea
40.1. Market Overview
40.2. Market Data
40.3. Market Segmentation
40.4. Market outlook
40.5. Five forces analysis
41 Macroeconomic Indicators
41.1. Country data
42 Generics in Spain
42.1. Market Overview
42.2. Market Data
42.3. Market Segmentation
42.4. Market outlook
42.5. Five forces analysis
43 Macroeconomic Indicators
43.1. Country data
44 Generics in Turkey
44.1. Market Overview
44.2. Market Data
44.3. Market Segmentation
44.4. Market outlook
44.5. Five forces analysis
45 Macroeconomic Indicators
45.1. Country data
46 Generics in The United Kingdom
46.1. Market Overview
46.2. Market Data
46.3. Market Segmentation
46.4. Market outlook
46.5. Five forces analysis
47 Macroeconomic Indicators
47.1. Country data
48 Generics in The United States
48.1. Market Overview
48.2. Market Data
48.3. Market Segmentation
48.4. Market outlook
48.5. Five forces analysis
49 Macroeconomic Indicators
49.1. Country data
50 Company Profiles
50.1. Teva Pharmaceutical Industries Ltd
50.2. Viatris Inc
50.3. Sun Pharmaceutical Industries Ltd
50.4. Novartis AG
50.5. Sandoz Group AG
50.6. Hikma Pharmaceuticals Plc
50.7. Sanofi
50.8. Les Laboratoires Servier SAS
50.9. Stada Arzneimittel AG
50.10. Bayer AG
50.11. Lupin Ltd
50.12. Aspen Pharmacare Holdings Ltd
50.13. EMS SA
50.14. Eurofarma Laboratorios SA
50.15. Ache Laboratorios Farmaceuticos SA
50.16. Apotex Inc
50.17. Teva Canada Ltd
50.18. Sandoz Canada Inc
50.19. CSPC Pharmaceutical Group Ltd
50.20. Sino Biopharmaceutical Ltd
50.21. Hansoh Pharmaceutical Group Co Ltd
50.22. Dr. Reddy's Laboratories Ltd
50.23. Cipla Ltd
50.24. Aurobindo Pharma Ltd
50.25. PT Kalbe Farma Tbk
50.26. PT Indofarma Tbk
50.27. PT Sanbe Farma
50.28. PT Soho Global Health Tbk
50.29. Friulchem SpA
50.30. DOC Generici SRL
50.31. Recordati SpA
50.32. Daiichi Sankyo Co Ltd
50.33. Towa Pharmaceutical Co Ltd
50.34. Sawai Group Holdings Co Ltd
50.35. Toho Holdings Co Ltd
50.36. Laboratorios Silanes SA de CV
50.37. Pfizer Inc
50.38. Biocad
50.39. R-Pharm
50.40. Pharmstandard
50.41. AstraZeneca Plc
50.42. Bluefish Pharmaceuticals AB
50.43. Navamedic ASA
50.44. Novartis International AG
50.45. Beacons Pharmaceuticals Pte Ltd
50.46. Abbott Laboratories SA
50.47. Adcock Ingram Holdings Ltd
50.48. Dongkook Pharmaceutical Co Ltd
50.49. JW Holdings Corp
50.50. Hanmi Pharmaceuticals Co Ltd
50.51. Dong Wha Pharma Co Ltd
50.52. Esteve Pharmaceuticals SA
50.53. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
50.54. Deva Holding AS
50.55. Sandoz Inc
51 Appendix
51.1. Methodology
51.2. About MarketLine
List of Tables
Table 1: Global generics market value: $ million, 2018-23
Table 2: Global generics market volume: % of total pharma volume, 2018-23
Table 3: Global generics market geography segmentation: $ million, 2023
Table 4: Global generics market value forecast: $ million, 2023-28
Table 5: Global generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Global Size of Population (million), 2019-23
Table 7: Global real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 8: Global GDP (Current Prices, $ Billion), 2019-23
Table 9: Global Inflation, 2019-23
Table 10: Global Consumer Price Index (Absolute), 2019-23
Table 11: Global exchange rate, 2018-23
Table 12: Asia-Pacific generics market value: $ million, 2018-23
Table 13: Asia-Pacific generics market volume: % of total pharma volume, 2018-23
Table 14: Asia-Pacific generics market geography segmentation: $ million, 2023
Table 15: Asia-Pacific generics market value forecast: $ million, 2023-28
Table 16: Asia-Pacific generics market volume forecast: % of total pharma volume, 2023-28
Table 17: Europe generics market value: $ million, 2018-23
Table 18: Europe generics market volume: % of total pharma volume, 2018-23
Table 19: Europe generics market geography segmentation: $ million, 2023
Table 20: Europe generics market value forecast: $ million, 2023-28
Table 21: Europe generics market volume forecast: % of total pharma volume, 2023-28
Table 22: Europe Size of Population (million), 2019-23
Table 23: Europe real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 24: Europe GDP (Current Prices, $ Billion), 2019-23
Table 25: Europe Inflation, 2019-23
Table 26: Europe Consumer Price Index (Absolute), 2019-23
Table 27: Europe exchange rate, 2018-23
Table 28: France generics market value: $ million, 2018-23
Table 29: France generics market volume: % of total pharma volume, 2018-23
Table 30: France generics market geography segmentation: $ million, 2023
Table 31: France generics market value forecast: $ million, 2023-28
Table 32: France generics market volume forecast: % of total pharma volume, 2023-28
Table 33: France Size of Population (million), 2019-23
Table 34: France real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 35: France GDP (Current Prices, $ Billion), 2019-23
Table 36: France Inflation, 2019-23
Table 37: France Consumer Price Index (Absolute), 2019-23
Table 38: France exchange rate, 2018-23
Table 39: Germany generics market value: $ million, 2018-23
Table 40: Germany generics market volume: % of total pharma volume, 2018-23
Table 41: Germany generics market geography segmentation: $ million, 2023
Table 42: Germany generics market value forecast: $ million, 2023-28
Table 43: Germany generics market volume forecast: % of total pharma volume, 2023-28
Table 44: Germany Size of Population (million), 2019-23
Table 45: Germany real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 46: Germany GDP (Current Prices, $ Billion), 2019-23
Table 47: Germany Inflation, 2019-23
Table 48: Germany Consumer Price Index (Absolute), 2019-23
Table 49: Germany exchange rate, 2018-23
Table 50: Australia generics market value: $ million, 2018-23
Table 51: Australia generics market volume: % of total pharma volume, 2018-23
Table 52: Australia generics market geography segmentation: $ million, 2023
Table 53: Australia generics market value forecast: $ million, 2023-28
Table 54: Australia generics market volume forecast: % of total pharma volume, 2023-28
Table 55: Australia Size of Population (million), 2019-23
Table 56: Australia real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 57: Australia GDP (Current Prices, $ Billion), 2019-23
Table 58: Australia Inflation, 2019-23
Table 59: Australia Consumer Price Index (Absolute), 2019-23
Table 60: Australia exchange rate, 2018-23
Table 61: Brazil generics market value: $ million, 2018-23
Table 62: Brazil generics market volume: % of total pharma volume, 2018-23
Table 63: Brazil generics market geography segmentation: $ million, 2023
Table 64: Brazil generics market value forecast: $ million, 2023-28
Table 65: Brazil generics market volume forecast: % of total pharma volume, 2023-28
Table 66: Brazil Size of Population (million), 2019-23
Table 67: Brazil real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 68: Brazil GDP (Current Prices, $ Billion), 2019-23
Table 69: Brazil Inflation, 2019-23
Table 70: Brazil Consumer Price Index (Absolute), 2019-23
Table 71: Brazil exchange rate, 2018-23
Table 72: Canada generics market value: $ million, 2018-23
Table 73: Canada generics market volume: % of total pharma volume, 2018-23
Table 74: Canada generics market geography segmentation: $ million, 2023
Table 75: Canada generics market value forecast: $ million, 2023-28
Table 76: Canada generics market volume forecast: % of total pharma volume, 2023-28
Table 77: Canada Size of Population (million), 2019-23
Table 78: Canada real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 79: Canada GDP (Current Prices, $ Billion), 2019-23
Table 80: Canada Inflation, 2019-23
Table 81: Canada Consumer Price Index (Absolute), 2019-23
Table 82: Canada exchange rate, 2018-23
Table 83: China generics market value: $ million, 2018-23
Table 84: China generics market volume: % of total pharma volume, 2018-23
Table 85: China generics market geography segmentation: $ million, 2023
Table 86: China generics market value forecast: $ million, 2023-28
Table 87: China generics market volume forecast: % of total pharma volume, 2023-28
Table 88: China Size of Population (million), 2019-23
Table 89: China real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 90: China GDP (Current Prices, $ Billion), 2019-23
Table 91: China Inflation, 2019-23
Table 92: China Consumer Price Index (Absolute), 2019-23
Table 93: China exchange rate, 2018-23
Table 94: India generics market value: $ million, 2018-23
Table 95: India generics market volume: % of total pharma volume, 2018-23
Table 96: India generics market geography segmentation: $ million, 2023
Table 97: India generics market value forecast: $ million, 2023-28
Table 98: India generics market volume forecast: % of total pharma volume, 2023-28
Table 99: India Size of Population (million), 2019-23
Table 100: India real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 101: India GDP (Current Prices, $ Billion), 2019-23
Table 102: India Inflation, 2019-23

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us